Skip to main content

Epicrispr Biotechnologies

South San Francisco, United States

Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.

$68.0M raised
Mar 2025
Series B

Top Investors

Ally Bridge GroupSolve FSHD

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Epicrispr Biotechnologies

How much funding has Epicrispr Biotechnologies raised?
Epicrispr Biotechnologies has raised $68.0M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Who are Epicrispr Biotechnologies's investors?
Epicrispr Biotechnologies's investors include Ally Bridge Group, Solve FSHD.
Where is Epicrispr Biotechnologies headquartered?
Epicrispr Biotechnologies is headquartered in South San Francisco, United States.
What does Epicrispr Biotechnologies do?
Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.
What stage is Epicrispr Biotechnologies at?
Epicrispr Biotechnologies is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Epicrispr Biotechnologies — Funding & Investors." VCBacked, March 26, 2025, https://www.vcbacked.co/company/epicrispr-biotechnologies. Accessed June 17, 2026.
APA
VCBacked. (2025). Epicrispr Biotechnologies — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/epicrispr-biotechnologies
Wikipedia (cite web)
{{cite web |title=Epicrispr Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/epicrispr-biotechnologies |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .